Senescent “zombie” cells accumulate as we age, releasing inflammatory signals that damage surrounding tissue. Senovax takes a novel approach: train the immune system to recognize these cells and eliminate them. By exposing dendritic immune cells to lab-generated senescent cells, the body learns the markers that identify aging cells. The result: the immune system creates a “wanted poster” and begins targeting senescent cells throughout the body. Unlike drugs that must reach specific tissues, the immune system already travels everywhere — and it remembers. One treatment could potentially provide long-lasting protection.